复宏汉霖午前涨超5% 近日于ASCO 2025年会上首次披露HLX43相关临床试验数据

智通财经
09 Jun

复宏汉霖(02696)午前涨超5%,截至发稿,涨5.2%,报48.02港元,成交额3850.02万港元。消息面上,近日,在ASCO2025年会期间,复宏汉霖连续发布多项围绕癌症治疗的最新突破,受到高度关注。本次ASCO年会上,复宏汉霖首次公布了HLX43(PD-L1ADC)治疗晚期/转移性实体瘤患者的I期临床试验数据。目前,全球范围内尚无PD-L1ADC获批上市,HLX43有望解决PD-1/L1...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10